跳至主要内容
临床试验/IRCT20180618040127N2
IRCT20180618040127N2尚未招募3 期

Evaluating the effect of probiotics on clinical signs, inflammatory and viral factors in patients with myelopathy secondary to HTLV-1

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • positive serology for HTLV-1
  • Occurrence of spastic paraparesia
  • Existence of anti HTLV-1 antibody in cerebrospinal fluid
  • Rule out of other etiologies of spastic paraparesia
  • MDG less than 9
  • Disease duration of less than 15 years
  • Informed consent for participating in the study

排除标准

  • Existence of other comorbidities
  • Receiving other drug which influence immune system

研究者

相似试验